Conference abstractPublished 18 Dec 2017
MicroRNA-145 functions as a tumor suppressor by targeting matrix metalloproteinase 11 and Rab GTPase family 27a in triple negative breast cancer
Nanjing Medical University, China
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Through increasing evidences have documented that microRNA-145 (miR-145) acts as a tumor suppressor in breast cancer, its exact role in triple negative breast cancer (TNBC) remains poorly defined. In this study, the expression of miR-145 in human TNBC cells and samples from 30 patients was analyzed by stem-loop real-time PCR. We found that miR-145 was significantly downregulated in TNBC tissues and cells. Upregulating miR-145 in HCC1937 cells dramatically suppressed cell proliferation and induced G1 phase arrest, whereas MDA-MB-231 cells did not show growth inhibition. MiR-145 exhibited inhibitory role in cell invasion through the post-transcriptional regulation of the novel targets MMP11 and Rab27a in TNBC cells. Additionally, miR-145 silencing could be reversed by DAC. These results demonstrated that miR-145 plays inhibitory role in TNBC malignancy by targeting MMP11 and Rab27a, which might be potential therapeutic and diagnostic targets for TNBC.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBreast Cancer: Current Research
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Feng Yan”